EFFECTS OF DISRUPTION OF THE PLASMINOGEN GENE ON THROMBOSIS, GROWTH, AND HEALTH IN MICE

被引:302
|
作者
PLOPLIS, VA
CARMELIET, P
VAZIRZADEH, S
VANVLAENDEREN, I
MOONS, L
PLOW, EF
COLLEN, D
机构
[1] KATHOLIEKE UNIV LEUVEN VIB, CTR TRANSGENE TECHNOL & GENE THERAPY, B-3000 LOUVAIN, BELGIUM
[2] CLEVELAND CLIN FDN, JOSEPH J JACOBS CTR THROMBOSIS & VASC BIOL, CLEVELAND, OH 44195 USA
[3] CLEVELAND CLIN FDN, DEPT MOLEC CARDIOL, CLEVELAND, OH 44195 USA
关键词
GENES; FIBRINOLYSIS; THROMBOLYSIS;
D O I
10.1161/01.CIR.92.9.2585
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Circumstantial evidence suggests that the plasminogen/plasmin system plays a role in many biological processes, including hemostasis, cell migration, and development. Methods and Results The in vivo function of the plasminogen/plasmin system was studied by generation of plasminogen-deficient (Plg(-/-)) mice. Inactivation of the murine plasminogen gene (Plg) was achieved by replacing, via homologous recombination in embryonic stem cells, genomic sequences encoding the exons containing the catalytic site amino acids His(605) and Asp(648) with a neomycin phosphotransferase expression cassette. Germline transmission of the mutated allele, as determined by Southern blot hybridization and polymerase chain reaction, was obtained via blastocyst injection. Mendelian inheritance of the inactivated plasminogen allele was observed, and homozygous-deficient mice (Plg(-/-)) displayed normal viability but retarded growth up to at least 12 weeks of age. At 8 weeks of age, body weight was 21.8 +/- 1.2 g (n=10) for wild-type (Plg(+/+)) mice, 21.0 +/- 1.1 g (n=16) for heterozygous-deficient (Plg(+/-)) mice, and 17.4 +/- 1.3 g (n=12) for Plg(-/-) mice; P<.05 versus Plg(+/+) or Plg(+/-). None of 36 Plg(+/+) or 65 Plg(+/-) mice but 7 of 37 Plg(-/-) mice (19%) developed rectal prolapse at 7.4 +/- 0.6 weeks of age (P=.03 versus Plg(-/-) and P=.003 versus Plg(+/-)); 4 of 37 Plg(-/-) mice (11%) became runted and apathic at 5.3 +/- 0.3 weeks of age (P=.041 versus Plg(+/-)); and 6 of 37 Plg(-/-) mice (16%) died prematurely at 8.8 +/- 1.7 weeks of age (P=.057 versus Plg(+/+) and P=.029 versus Plg(+/-)). Although male and female Plg(-/-) mice were able to sire offspring, the fertility of Plg(-/-) female mice was reduced, possibly owing to their impaired health. Levels of plasminogen-related antigen in plasma, measured by ELISA, were 84 +/- 8 mu g/mL (n=4) in Plg(+/+), 35 +/- 2 mu g/mL (n=3) in Plg(+/-), and 0.076 +/- 0.032 mu g/mL (n=6) in Plg(-/-) mice (P<.001 versus Plg(+/-) and Pig(+/+)). Plasmin activity generated by urokinase activation was unmeasurable in PEg(-/-) mice (<5% of Plg(+/+) mice). Plasminogen-specific immunoreactivity was observed in hepatocytes from Plg(+/+) mice but not from Plg(-/-) mice (<10% of Plg(+/+) mice). Neither native nor variant plasminogen mRNA nor translation products could be identified by Northern or Western blot of liver extracts from Plg(-/-) mice. Spontaneous lysis within 24 hours of a I-125-fibrin-labeled pulmonary plasma clot was 85 +/- 5% (n=5) in Plg(+/+) mice, 62 +/- 7% (n=3) in Plg(+/-) mice, and -2 +/- 1% (n=3) in Plg(-/-) mice (P<.001 versus Plg(+/-) and Plg(+/+)). Delayed clot lysis within 72 hours was 33 +/- 1% (n=3) in tPA(-/-) mice and 26 +/- 2% (n=3) in Plg(-/-) mice (P=.054). Histological examination of several organs revealed fibrin deposition in the liver; lung; and in the stomach, associated with gastric ulcers, in 6- to Ii-week-old Plg(-/-) mice but not in Plg(+/+) or Plg(+/-) littermates. Conclusions Plasminogen-deficient mice survive embryonic development but develop spontaneous fibrin deposition due to impaired thrombolysis and suffer retarded growth and reduced fertility and survival. The Plg(-/-) phenotype is reminiscent of the combined tPA(-/-):uPA(-/-) phenotype, which suggests that there is no significant additional pathway for physiological plasminogen activation in mice.
引用
收藏
页码:2585 / 2593
页数:9
相关论文
共 50 条
  • [31] Impaired wound healing in mice with a disrupted plasminogen gene
    Romer, J
    Bugge, TH
    Pyke, C
    Lund, LR
    Flick, MJ
    Degen, JL
    Dano, K
    NATURE MEDICINE, 1996, 2 (03) : 287 - 292
  • [32] Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice
    Eitzman, DT
    Westrick, RJ
    Nabel, EG
    Ginsburg, D
    BLOOD, 2000, 95 (02) : 577 - 580
  • [33] Disruption of the insulin-like growth factor-1 gene in osteocytes impairs developmental bone growth in mice
    Sheng, Matilda H. -C.
    Zhou, Xiao-Dong
    Bonewald, Lynda F.
    Baylink, David J.
    Lau, K. -H. William
    BONE, 2013, 52 (01) : 133 - 144
  • [34] BIOLOGICAL EFFECTS OF COMBINED INACTIVATION OF PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE-FUNCTION IN MICE
    LIJNEN, HR
    MOONS, L
    BEELEN, V
    CARMELIET, P
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1995, 74 (04) : 1126 - 1131
  • [35] EFFECTS OF DISRUPTION OF CNTF GENE IN THE MOUSE
    DREYFUS, JC
    M S-MEDECINE SCIENCES, 1993, 9 (11): : 1269 - 1269
  • [36] Effects of selenium supplementation on diet-induced obesity in mice with a disruption of the selenocysteine lyase gene
    Watanabe, Ligia M.
    Hashimoto, Ann C.
    Torres, Daniel J.
    Berry, Marla J.
    Seale, Lucia A.
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2020, 62
  • [37] Mice carrying a CD20 gene disruption
    O'Keefe, TL
    Williams, GT
    Davies, SL
    Neuberger, MS
    IMMUNOGENETICS, 1998, 48 (02) : 125 - 132
  • [38] Targeted gene disruption of natural anticoagulant proteins in mice
    Tetsuhito Kojima
    International Journal of Hematology, 2002, 76 : 36 - 39
  • [39] Retinopathy induced in mice by targeted disruption of the rhodopsin gene
    Humphries, MM
    Rancourt, D
    Farrar, GJ
    Kenna, P
    Hazel, M
    Bush, RA
    Sieving, PA
    Sheils, DM
    McNally, N
    Creighton, P
    Erven, A
    Boros, A
    Gulya, K
    Capecchi, MR
    Humphries, P
    NATURE GENETICS, 1997, 15 (02) : 216 - 219
  • [40] Retinopathy induced in mice by targeted disruption of the rhodopsin gene
    Marian M. Humphries
    Derrick Rancourt
    G. Jane Farrar
    Paul Kenna
    Mark Hazel
    Ronald A. Bush
    Paul A. Sieving
    Denise M. Sheils
    Peter Creighton
    Alexandra Erven
    Andras Boros
    Karoly Gulya
    Mario R. Capecchi
    Peter Humphries
    Nature Genetics, 1997, 15 : 216 - 219